A naukri.com initiative
Bioengineer
1w
249
Image Credit: Bioengineer
Celebrating Dr. Mikhail Blagosklonny’s Vision: Unraveling Hyperfunction Theory and the Promise of Rapamycin
- Dr. Mikhail Blagosklonny is known for his hyperfunction theory and research on the mechanistic target of rapamycin (mTOR) pathway.
- He viewed aging not as a result of accumulating damage but as an active biological process driven by the body’s growth signals.
- He advocated for the use of rapamycin, an mTOR inhibitor, as a potential therapeutic agent to extend healthy lifespan and improve immune function by increasing vaccine efficacy.
- Rapamycin is emerging as a candidate for protective strategies against malignancies as it could simultaneously act as a preventative measure and a therapeutic agent.
- Blagosklonny's legacy includes a shift in traditional views on mortality and degenerative health as inevitable, promoting preventive strategies and personalized therapies to manage aging.
- Researchers are tasked with a dual mission of unearthing the intricacies of aging mechanisms and providing evidence-based interventions that can be broadly applied.
- Well-designed clinical trials are critical to ascertain the safety and effectiveness of longevity interventions and maintain public trust in new age-related therapies.
- Geroscience offers a foundation for researchers to explore aging biology, disease prevention, and therapeutic innovation to improve the quality of life for individuals as they age.
- The legacy of Blagosklonny inspires hope for a future where aging can be constructively managed through scientific discoveries that are accessible and beneficial to all.
- The field of geroscience is evolving, and researchers are advancing towards unveiling the secrets of prolonged health and vitality, a mission that Dr. Blagosklonny championed.
Read Full Article
15 Likes
For uninterrupted reading, download the app